Horizon: the EU Research & Innovation Magazine. Researchers may have found ways to make a vaccine against all strains of the flu virus, potentially saving millions of lives. Last year’s flu vaccine rarely works on this year’s strain due to the … Continue reading
Arwen F. Altenburg, Joost H. C. M. Kreijtz, Rory D. de Vries, Fei Song, Robert Fux, Guus F. Rimmelzwaan, Gerd Sutter and Asisa Volz (2014) Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory … Continue reading
Asisa Volz, Martin Langenmayer, Sylvia Jany, Ulrich Kalinke and Gerd Sutter (2014) Rapid expansion of CD8+ T cells in wildtype and type I interferon receptor deficient mice correlates with protection after low-dose emergency immunization with Modified Vaccinia virus Ankara. Journal of Virology Published … Continue reading
FLUNIVAC aims at developing a candidate influenza vaccine based on recombinant Modified Vaccinia virus Ankara viruses (rMVA) encoding both B-cell and T- cell response-inducing proteins, ready to commence Phase I clinical trials. We focus on influenza A virus since it … Continue reading
FLUNIVAC is an SME-targeted collaborative research project funded by the EU FP7 program, aiming at developing a universal influenza vaccine that provides long-lasting and broad protection against multiple strains of influenza A virus.